(Q52548115)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Zhao Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Michael Maricic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Paul Nguyen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Frederick R Ahmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Bruce L Dalkin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

2136-2144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12412167%20AND%20SRC:MED&resulttype=core&format=json

Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Prevalence of low femoral bone density in older U.S. adults from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Effect of age on bone density and bone turnover in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Comorbidities of overweight and obesity: current evidence and research issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Anthropometric risk factors for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Serum testosterone and its relation to bone mineral density and body composition in normal males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Updated data on proximal femur bone mineral levels of US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Overweight as an avoidable cause of cancer in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Obesity and its comorbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Android obesity at diagnosis and breast carcinoma survival: Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span,and survival from breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Long-term effects of androgen deprivation therapy in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Low bone mineral density in hormone-naïve men with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Gonadotrophin-releasing hormone agonists induce osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Obesity, body fat distribution and body build: Their relation to blood pressure and prevalence of hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Osteoporosis in men with idiopathic hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

The diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Links between genetic and environmental factors and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10967

7 January 2021